vs

Side-by-side financial comparison of Offerpad Solutions Inc. (OPAD) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Oncology Institute, Inc. is the larger business by last-quarter revenue ($142.0M vs $114.1M, roughly 1.2× Offerpad Solutions Inc.). On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs -34.5%). Offerpad Solutions Inc. produced more free cash flow last quarter ($65.7M vs $2.2M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs -36.8%).

Offerpad Solutions Inc is a prominent U.S. proptech firm focused on simplifying residential real estate transactions. Operating under the iBuyer model, it purchases homes directly from sellers, conducts required renovations, and resells properties to buyers. It also provides supporting services including mortgage assistance, title services, and flexible moving options for clients across dozens of U.S. states.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

OPAD vs TOI — Head-to-Head

Bigger by revenue
TOI
TOI
1.2× larger
TOI
$142.0M
$114.1M
OPAD
Growing faster (revenue YoY)
TOI
TOI
+76.1% gap
TOI
41.6%
-34.5%
OPAD
More free cash flow
OPAD
OPAD
$63.6M more FCF
OPAD
$65.7M
$2.2M
TOI
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
-36.8%
OPAD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
OPAD
OPAD
TOI
TOI
Revenue
$114.1M
$142.0M
Net Profit
$-7.5M
Gross Margin
7.0%
Operating Margin
-4.9%
Net Margin
-5.3%
Revenue YoY
-34.5%
41.6%
Net Profit YoY
49.1%
43.0%
EPS (diluted)
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OPAD
OPAD
TOI
TOI
Q4 25
$114.1M
$142.0M
Q3 25
$132.7M
$136.6M
Q2 25
$160.3M
$119.8M
Q1 25
$160.7M
$104.4M
Q4 24
$174.3M
$100.3M
Q3 24
$208.1M
$99.9M
Q2 24
$251.1M
$98.6M
Q1 24
$285.4M
$94.7M
Net Profit
OPAD
OPAD
TOI
TOI
Q4 25
$-7.5M
Q3 25
$-11.6M
$-16.5M
Q2 25
$-10.9M
$-17.0M
Q1 25
$-15.1M
$-19.6M
Q4 24
$-17.3M
$-13.2M
Q3 24
$-13.5M
$-16.1M
Q2 24
$-13.8M
$-15.5M
Q1 24
$-17.5M
$-19.9M
Gross Margin
OPAD
OPAD
TOI
TOI
Q4 25
7.0%
Q3 25
7.0%
Q2 25
8.9%
Q1 25
6.5%
Q4 24
6.1%
Q3 24
8.2%
Q2 24
8.7%
Q1 24
7.9%
Operating Margin
OPAD
OPAD
TOI
TOI
Q4 25
-4.9%
Q3 25
-5.1%
-5.9%
Q2 25
-4.9%
-9.4%
Q1 25
-7.2%
-9.5%
Q4 24
-7.8%
-11.9%
Q3 24
-4.3%
-13.9%
Q2 24
-3.9%
-16.6%
Q1 24
-4.8%
-19.0%
Net Margin
OPAD
OPAD
TOI
TOI
Q4 25
-5.3%
Q3 25
-8.7%
-12.1%
Q2 25
-6.8%
-14.2%
Q1 25
-9.4%
-18.8%
Q4 24
-9.9%
-13.1%
Q3 24
-6.5%
-16.1%
Q2 24
-5.5%
-15.7%
Q1 24
-6.1%
-21.0%
EPS (diluted)
OPAD
OPAD
TOI
TOI
Q4 25
$-0.04
Q3 25
$-0.37
$-0.14
Q2 25
$-0.39
$-0.15
Q1 25
$-0.55
$-0.21
Q4 24
$-0.64
$-0.14
Q3 24
$-0.49
$-0.18
Q2 24
$-0.50
$-0.17
Q1 24
$-0.64
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OPAD
OPAD
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$26.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$38.2M
$-15.7M
Total Assets
$154.8M
$164.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OPAD
OPAD
TOI
TOI
Q4 25
$26.5M
Q3 25
$31.0M
Q2 25
$22.6M
Q1 25
$30.8M
Q4 24
$43.0M
Q3 24
$48.5M
Q2 24
$56.9M
$9.9M
Q1 24
$68.5M
$29.8M
Stockholders' Equity
OPAD
OPAD
TOI
TOI
Q4 25
$38.2M
$-15.7M
Q3 25
$39.9M
$-12.3M
Q2 25
$24.5M
$-9.0M
Q1 25
$34.2M
$5.1M
Q4 24
$47.7M
$3.6M
Q3 24
$64.7M
$15.5M
Q2 24
$77.6M
$29.2M
Q1 24
$88.1M
$41.3M
Total Assets
OPAD
OPAD
TOI
TOI
Q4 25
$154.8M
$164.7M
Q3 25
$223.5M
$163.6M
Q2 25
$268.0M
$159.8M
Q1 25
$274.5M
$164.0M
Q4 24
$313.1M
$172.7M
Q3 24
$338.5M
$179.2M
Q2 24
$406.6M
$179.6M
Q1 24
$369.7M
$204.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OPAD
OPAD
TOI
TOI
Operating Cash FlowLast quarter
$66.8M
$3.2M
Free Cash FlowOCF − Capex
$65.7M
$2.2M
FCF MarginFCF / Revenue
57.6%
1.5%
Capex IntensityCapex / Revenue
0.9%
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OPAD
OPAD
TOI
TOI
Q4 25
$66.8M
$3.2M
Q3 25
$40.0M
$-12.6M
Q2 25
$-13.5M
$-10.2M
Q1 25
$-10.2M
$-5.0M
Q4 24
$20.8M
$4.2M
Q3 24
$39.6M
$819.0K
Q2 24
$-54.4M
$-15.7M
Q1 24
$2.4M
$-15.9M
Free Cash Flow
OPAD
OPAD
TOI
TOI
Q4 25
$65.7M
$2.2M
Q3 25
$-13.2M
Q2 25
$-13.6M
$-11.4M
Q1 25
$-11.2M
$-5.3M
Q4 24
$15.4M
$2.4M
Q3 24
$38.7M
$417.0K
Q2 24
$-54.4M
$-17.5M
Q1 24
$2.0M
$-16.5M
FCF Margin
OPAD
OPAD
TOI
TOI
Q4 25
57.6%
1.5%
Q3 25
-9.7%
Q2 25
-8.5%
-9.5%
Q1 25
-7.0%
-5.1%
Q4 24
8.9%
2.4%
Q3 24
18.6%
0.4%
Q2 24
-21.7%
-17.7%
Q1 24
0.7%
-17.4%
Capex Intensity
OPAD
OPAD
TOI
TOI
Q4 25
0.9%
0.7%
Q3 25
0.0%
0.4%
Q2 25
0.1%
1.0%
Q1 25
0.6%
0.3%
Q4 24
3.1%
1.8%
Q3 24
0.4%
0.4%
Q2 24
0.0%
1.9%
Q1 24
0.1%
0.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OPAD
OPAD

Segment breakdown not available.

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons